Work

Clinical progress of engineered cellular immunotherapies for autoimmunity

Year: 2026

Type: review

Source: Nature Biotechnology

DOI: 10.1038/s41587-026-03001-x

Authors: Farzan Solimani, Masayuki Amagai, Catherine M. Bollard, Aimee S. Payne

Institutions: Humboldt-Universität zu Berlin, Columbia University, Charité – Universitätsmedizin Berlin, Keio University, RIKEN Center for Integrative Medical Sciences, Children's National, Columbia University Irving Medical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Myasthenia Gravis Foundation of America, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: Dissecting mechanisms of functional cell death "corneoptosis" and stratum corneum homeostasis regulated by pH and its clinical application, G2967014192, Engineering disease-specific T cells for pemphigus therapy, NextGen - CRI, G5012274019, Translating cellular immunotherapies for autoimmunity to canine clinical trials, G8748437548, Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris, BMT CTN Core: Baylor College of Medicine Consortium

OpenAlex ID: W7129099681

FWCI: 7.393

Cites: 165

Cited by: 8

Related to: 10